{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:04:09Z","timestamp":1777982649858,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11610-7","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:33:44Z","timestamp":1772192024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Altered expression and mutations in cell cycle genes CCND1, CDK4, CDKN2B and TP53 are associated with Pakistani breast cancer patients"],"prefix":"10.1007","volume":"53","author":[{"given":"Wajeeha","family":"Tariq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Raza","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim Khalid","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Wasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"17","key":"11610_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174287","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanis\u0142awek A (2021) Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014an updated review. Cancer 13(17):4287. https:\/\/doi.org\/10.3390\/cancers13174287","journal-title":"Cancer"},{"issue":"11","key":"11610_CR2","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.7314\/APJCP.2014.15.11.4411","volume":"15","author":"HM Asif","year":"2014","unstructured":"Asif HM, Sultana S, Akhtar N, Rehman JU, Rehman (2014) Prevalence, risk factors and disease knowledge of breast cancer in Pakistan. Asian Pac J Cancer Prev 15(11):4411\u20134416. https:\/\/doi.org\/10.7314\/APJCP.2014.15.11.4411","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"11610_CR3","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1177\/000313481007601216","volume":"76","author":"J Sariego","year":"2010","unstructured":"Sariego J (2010) The impact of facility volume\/size on breast cancer treatment and outcome. Am Surg 76(12):1333\u20131337. https:\/\/doi.org\/10.1177\/000313481007601216","journal-title":"Am Surg"},{"key":"11610_CR4","first-page":"79","volume":"19","author":"S Baloch","year":"2014","unstructured":"Baloch S, Memon F, Gill RC, Bawa A, Quraishy MS (2014) Early breast cancer in females presenting with palpable breast lumps. J Surg Pakistan 19:79\u201381","journal-title":"J Surg Pakistan"},{"issue":"8","key":"11610_CR5","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.7314\/APJCP.2014.15.8.3353","volume":"15","author":"W Majeed","year":"2014","unstructured":"Majeed W, Aslam B, Javed I, Khaliq T, Muhammad F, Ali A, Raza AJ (2014) Breast cancer: major risk factors and recent developments in treatment. Asian Pac J Cancer Prev 15(8):3353\u20133358. https:\/\/doi.org\/10.7314\/APJCP.2014.15.8.3353","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"11610_CR6","first-page":"1812","volume":"54","author":"C Gillett","year":"1994","unstructured":"Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54(7):1812\u20131817","journal-title":"Cancer Res"},{"issue":"8","key":"11610_CR7","first-page":"2127","volume":"8","author":"MF Buckley","year":"1993","unstructured":"Buckley MF, Sweeney K, Hamilton J, Sini R, Manning D, Nicholson R, Watts C, Musgrove E, Sutherland R (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8(8):2127\u20132133","journal-title":"Oncogene"},{"issue":"6318","key":"11610_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/350512a0","volume":"350","author":"T Motokura","year":"1991","unstructured":"Motokura T, Bloom T, Kim HG, J\u00fcppner H, Ruderman JV, Kronenberg HM, Arnold A (1991) A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350(6318):512\u2013515","journal-title":"Nature"},{"issue":"2","key":"11610_CR9","first-page":"355","volume":"7","author":"E Schuuring","year":"1992","unstructured":"Schuuring E, Verhoeven E, Mooi W, Michalides R (1992) Identification and cloning of two overexpressed genes, U21B31\/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7(2):355\u2013361","journal-title":"Oncogene"},{"issue":"4","key":"11610_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4161\/cc.9.4.10611","volume":"9","author":"S Paternot","year":"2010","unstructured":"Paternot S, Bockstaele L, Bisteau X, Kooken H, Coulonval K, Roger P (2010) Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell Cycle 9(4):689\u2013699. https:\/\/doi.org\/10.4161\/cc.9.4.10611","journal-title":"Cell Cycle"},{"issue":"1","key":"11610_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22327-5","volume":"12","author":"Y Xia","year":"2021","unstructured":"Xia Y, Liu Y, Yang C, Simeone DM, Sun T-T, DeGraff DJ, Tang M-s, Zhang Y, Wu X-R (2021) Dominant role of CDKN2B\/p15INK4B of 9p21. 3 tumor suppressor hub in inhibition of cell-cycle and glycolysis. Nat Commun 12(1):2047. https:\/\/doi.org\/10.1038\/s41467-021-22327-5","journal-title":"Nat Commun"},{"issue":"13","key":"11610_CR12","doi-asserted-by":"publisher","first-page":"8600","DOI":"10.1074\/jbc.M507611200","volume":"281","author":"Y Tomita","year":"2006","unstructured":"Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, Klein C, Pan H, Kessler H, Pancoska P, Moll UM (2006) WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem 281(13):8600\u20138606. https:\/\/doi.org\/10.1074\/jbc.M507611200","journal-title":"J Biol Chem"},{"issue":"50","key":"11610_CR13","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1038\/onc.2008.315","volume":"27","author":"EC Pietsch","year":"2008","unstructured":"Pietsch EC, Sykes SM, McMahon SB, Murphy ME (2008) The p53 family and programmed cell death. Oncogene 27(50):6507\u20136521","journal-title":"Oncogene"},{"issue":"3","key":"11610_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/humu.10174","volume":"21","author":"AL B\u00f8rresen-Dale","year":"2003","unstructured":"B\u00f8rresen-Dale AL (2003) TP53 and breast cancer. Hum Mutat 21(3):292\u2013300. https:\/\/doi.org\/10.1002\/humu.10174","journal-title":"Hum Mutat"},{"key":"11610_CR15","volume-title":"Molecular cloning: a laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold spring harbor laboratory press"},{"issue":"1","key":"11610_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11033-024-09223-z","volume":"51","author":"A Kamal","year":"2024","unstructured":"Kamal A, Awan AR, Rabbani M, Sheikh HR, Tayyab M, Firyal S, Khan IH, Wasim M (2024) The interplay of PTEN and AKT nexus in breast cancer: a molecular perspective. Mol Biol Rep 51(1):345. https:\/\/doi.org\/10.1007\/s11033-024-09223-z","journal-title":"Mol Biol Rep"},{"key":"11610_CR17","doi-asserted-by":"publisher","unstructured":"Yaqub HMF, Awan AR, Saif R, Firyal S, Tayyab M, Khan M-u-R, Wasim M (2023) MicroRNAs hsa-miR-222-3p, hsa-let-7b-5p, and hsa-let-7f-5p Regulate Their Putative Target Genes HMGA1 and CDKN1B in Pakistani Breast Cancer Patients. https:\/\/doi.org\/10.17582\/journal.pjz\/20230502070537","DOI":"10.17582\/journal.pjz\/20230502070537"},{"issue":"4","key":"11610_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"1","key":"11610_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot4455","volume":"2006","author":"J Sambrook","year":"2006","unstructured":"Sambrook J, Russell DW (2006) Purification of nucleic acids by extraction with phenol: chloroform. Cold Spring Harb Protoc 2006(1):prot4455. https:\/\/doi.org\/10.1101\/pdb.prot4455","journal-title":"Cold Spring Harb Protoc"},{"issue":"1","key":"11610_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2353\/jmoldx.2007.060081","volume":"9","author":"S Ogino","year":"2007","unstructured":"Ogino S, Gulley ML, den Dunnen JT, Wilson RB (2007) Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 9(1):1\u20136. https:\/\/doi.org\/10.2353\/jmoldx.2007.060081","journal-title":"J Mol Diagn"},{"issue":"4","key":"11610_CR21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/sj\/bjc\/6600109","volume":"86","author":"I Bieche","year":"2002","unstructured":"Bieche I, Olivi M, Nogues C, Vidaud M, Lidereau R (2002) Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer 86(4):580\u2013586. https:\/\/doi.org\/10.1038\/sj\/bjc\/6600109","journal-title":"Br J Cancer"},{"issue":"3","key":"11610_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/172460080001500301","volume":"15","author":"F Spyratos","year":"2000","unstructured":"Spyratos F, Andrieu C, Vidaud D, Briffod M, Vidaud M, Lidereau R, Bieche I (2000) CCND1 mRNA overexpression is highly related to estrogen receptor positivity but not to proliferative markers in primary breast cancer. Int J Biol Markers 15(3):210\u2013214. https:\/\/doi.org\/10.1177\/172460080001500301","journal-title":"Int J Biol Markers"},{"key":"11610_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10549-017-4294-5","volume":"164","author":"C Ahlin","year":"2017","unstructured":"Ahlin C, Lundgren C, Embrets\u00e9n-Varro E, Jirstr\u00f6m K, Blomqvist C, Fj\u00e4llskog M-L (2017) High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers. Breast Cancer Res Treat 164:667\u2013678. https:\/\/doi.org\/10.1007\/s10549-017-4294-5","journal-title":"Breast Cancer Res Treat"},{"issue":"7155","key":"11610_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature06046","volume":"448","author":"D Santamar\u00eda","year":"2007","unstructured":"Santamar\u00eda D, Barri\u00e8re C, Cerqueira A, Hunt S, Tardy C, Newton K, C\u00e1ceres JF, Dubus P, Malumbres M, Barbacid M (2007) Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448(7155):811\u2013815","journal-title":"Nature"},{"issue":"1","key":"11610_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1947601909358105","volume":"1","author":"HK Reddy","year":"2010","unstructured":"Reddy HK, Gra\u00f1a X, Dhanasekaran DN, Litvin J, Reddy EP (2010) Requirement of Cdk4 for v- Ha-ras\u2013induced breast tumorigenesis and activation of the v-ras\u2013induced senescence program by the R24C mutation. Genes Cancer 1(1):69\u201380. https:\/\/doi.org\/10.1177\/1947601909358105","journal-title":"Genes Cancer"},{"issue":"1","key":"11610_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.7314\/APJCP.2014.15.1.75","volume":"15","author":"K Bodoor","year":"2014","unstructured":"Bodoor K, Haddad Y, Alkhateeb A, Al-Abbadi A, Dowairi M, Magableh A, Bsoul N, Ghabkari A (2014) DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Asian Pac J Cancer Prev 15(1):75\u201384. https:\/\/doi.org\/10.7314\/APJCP.2014.15.1.75","journal-title":"Asian Pac J Cancer Prev"},{"key":"11610_CR27","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s13277-013-1198-9","volume":"35","author":"I Chaar","year":"2014","unstructured":"Chaar I, Amara S, Elamine OE, Khiari M, Ounissi D, Khalfallah T, Ben Hmida A, Mzabi S, Bouraoui S (2014) Biological significance of promoter hypermethylation of p14\/ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma. Tumor Biol 35:1439\u20131449. https:\/\/doi.org\/10.1007\/s13277-013-1198-9","journal-title":"Tumor Biol"},{"issue":"8","key":"11610_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4161\/epi.5.8.13276","volume":"5","author":"CR Geyer","year":"2010","unstructured":"Geyer CR (2010) Strategies to re-express epigenetically silenced p15 INK4b and p21 WAF1 genes in acute myeloid leukemia. Epigenetics 5(8):696\u2013703. https:\/\/doi.org\/10.4161\/epi.5.8.13276","journal-title":"Epigenetics"},{"issue":"6","key":"11610_CR29","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1002\/jcp.29388","volume":"235","author":"S Seifi","year":"2020","unstructured":"Seifi S, Pouya F, Rahmani M, Mehramiz M, Rastgar-Moghadam A, Gharib M, Rahmani F, Shahidsales S, Hassanian SM, Khazaei M (2020) Association of cyclin\u2010dependent kinase inhibitor 2A\/B with increased risk of developing breast cancer. J Cell Physiol 235(6):5141\u20135145. https:\/\/doi.org\/10.1002\/jcp.29388","journal-title":"J Cell Physiol"},{"issue":"1","key":"11610_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/jomfp.JOMFP_184_18","volume":"23","author":"VD Roshan","year":"2019","unstructured":"Roshan VD, Sinto M, Vargees BT, Kannan S (2019) Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer. J Oral Maxillofac Pathol 23(1):82\u201389. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_184_18","journal-title":"J Oral Maxillofac Pathol"},{"issue":"19","key":"11610_CR31","first-page":"4257","volume":"55","author":"X Chen","year":"1995","unstructured":"Chen X, Bargonetti J, Prives C (1995) P53, through p21 (WAF1\/CIP1), induces cyclin D1 synthesis. Cancer Res 55(19):4257\u20134263","journal-title":"Cancer Res"},{"issue":"4","key":"11610_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s42256-024-00823-9","volume":"6","author":"Y Chu","year":"2024","unstructured":"Chu Y, Yu D, Li Y, Huang K, Shen Y, Cong L, Zhang J, Wang M (2024) A 5\u2032 UTR language model for decoding untranslated regions of mRNA and function predictions. Nat Mach Intell 6(4):449\u2013460. https:\/\/doi.org\/10.1038\/s42256-024-00823-9","journal-title":"Nat Mach Intell"},{"issue":"4","key":"11610_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.trecan.2019.02.011","volume":"5","author":"SL Schuster","year":"2019","unstructured":"Schuster SL, Hsieh AC (2019) The untranslated regions of mRNAs in cancer. Trends Cancer 5(4):245\u2013262. https:\/\/doi.org\/10.1016\/j.trecan.2019.02.011","journal-title":"Trends Cancer"},{"issue":"1","key":"11610_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02745-0","volume":"9","author":"KA Cottrell","year":"2018","unstructured":"Cottrell KA, Chaudhari HG, Cohen BA, Djuranovic S (2018) PTRE-seq reveals mechanism and interactions of RNA binding proteins and miRNAs. Nat Commun 9(1):301. https:\/\/doi.org\/10.1038\/s41467-017-02745-0","journal-title":"Nat Commun"},{"issue":"1","key":"11610_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0994-0","volume":"17","author":"L Mularoni","year":"2016","unstructured":"Mularoni L, Sabarinathan R, Deu-Pons J, Gonzalez-Perez A, L\u00f3pez-Bigas N (2016) OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations. Genome Biol 17(1):128. https:\/\/doi.org\/10.1186\/s13059-016-0994-0","journal-title":"Genome Biol"},{"issue":"21","key":"11610_CR36","doi-asserted-by":"publisher","first-page":"15753","DOI":"10.1074\/jbc.M110.110742","volume":"285","author":"S Lammich","year":"2010","unstructured":"Lammich S, Buell D, Zilow S, Ludwig A-K, Nuscher B, Lichtenthaler SF, Prinzen C, Fahrenholz F, Haass C (2010) Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5\u2032-untranslated region. J Biol Chem 285(21):15753\u201315760. https:\/\/doi.org\/10.1074\/jbc.M110.110742","journal-title":"J Biol Chem"},{"issue":"6","key":"11610_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1515\/hsz-2018-0350","volume":"400","author":"F Marziali","year":"2019","unstructured":"Marziali F, Dizanzo MP, Cavatorta AL, Gardiol D (2019) Differential expression of DLG1 as a common trait in different human diseases: an encouraging issue in molecular pathology. Biol Chem 400(6):699\u2013710. https:\/\/doi.org\/10.1515\/hsz-2018-0350","journal-title":"Biol Chem"},{"issue":"8","key":"11610_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081419","volume":"11","author":"J Bekampyt\u0117","year":"2021","unstructured":"Bekampyt\u0117 J, Bartnykait\u0117 A, Savukaityt\u0117 A, Ugenskien\u0117 R, Korobeinikova E, Gudaitien\u0117 J, Juozaityt\u0117 E (2021) The investigation of associations between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 polymorphisms and breast cancer phenotype and prognosis. Diagnostics 11(8):1419. https:\/\/doi.org\/10.3390\/diagnostics11081419","journal-title":"Diagnostics"},{"issue":"6","key":"11610_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269893","volume":"17","author":"J Park","year":"2022","unstructured":"Park J, Kim C, Ki Y, Kim W, Nam J, Kim D, Park D, Jeon H, Kim DW, Joo JH (2022) Incidence of hypothyroidism after treatment for breast cancer: a Korean population-based study. PLoS One 17(6):e0269893. https:\/\/doi.org\/10.1371\/journal.pone.0269893","journal-title":"PLoS One"},{"key":"11610_CR40","unstructured":"Akhtar T, Arif S, Mushtaq Z, Gilani SO, Jamil M, Ayaz Y, Butt SI (eds) (2022) 2022 2nd International Conference of Smart Systems and Emerging Technologies (SMARTTECH)"},{"issue":"1","key":"11610_CR41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3892\/ol.2014.2617","volume":"9","author":"S Hryhorowicz","year":"2015","unstructured":"Hryhorowicz S, Ziemnicka K, Kaczmarek\u2013Ry\u015b M, Hoppe\u2013Go\u0142\u0119biewska J, P\u0142awski A, Skrzypczak\u2013Zieli\u0144ska M, Szkudlarek M, Go\u0142\u0105b M, Budny B, Rucha\u0142a M (2015) CCND1 gene polymorphic variants in patients with differentiated thyroid carcinoma. Oncol Lett 9(1):442\u2013448. https:\/\/doi.org\/10.3892\/ol.2014.2617","journal-title":"Oncol Lett"},{"issue":"3","key":"11610_CR42","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s11033-022-08202-6","volume":"50","author":"MA El-Eshmawy","year":"2023","unstructured":"El-Eshmawy MA, Shahin HE, El-Beltagy NS, Abdel Hamid D, Elfarargy OM, Elsayed DH, Elsaid AM, Elshazli RM, Mohamed NM (2023) Association of CCND1 (c. 723G\u2009>\u2009A, rs9344) variant with elevated risk of breast carcinoma: a retrospective case\u2013control study. Mol Biol Rep 50(3):2015\u20132024. https:\/\/doi.org\/10.1007\/s11033-022-08202-6","journal-title":"Mol Biol Rep"},{"key":"11610_CR43","unstructured":"Silva SN, Gomes BC, Gaspar JF, Rueff J (2011) DNA repair perspectives in thyroid and breast cancer: the role of DNA repair polymorphisms. INTECH Open Access"},{"key":"11610_CR44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10549-008-0195-y","volume":"116","author":"C Lu","year":"2009","unstructured":"Lu C, Dong J, Ma H, Jin G, Hu Z, Peng Y, Guo X, Wang X, Shen H (2009) CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 116:571\u2013575. https:\/\/doi.org\/10.1007\/s10549-008-0195-y","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"11610_CR45","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1158\/1078-0432.CCR-07-4368","volume":"14","author":"CJ Marsit","year":"2008","unstructured":"Marsit CJ, Black CC, Posner MR, Kelsey KT (2008) A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck. Clin Cancer Res 14(8):2371\u20132377. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4368","journal-title":"Clin Cancer Res"},{"key":"11610_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00405-005-0957-7","volume":"263","author":"M Rydzanicz","year":"2006","unstructured":"Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W, Szyfter K (2006) Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol 263:43\u201348. https:\/\/doi.org\/10.1007\/s00405-005-0957-7","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"11610_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154401","volume":"106","author":"C Lin","year":"2022","unstructured":"Lin C, Zeng Z, Lin Y, Wang P, Cao D, Xie K, Luo Y, Yang H, Yang J, Wang W (2022) Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota. Phytomedicine 106:154401. https:\/\/doi.org\/10.1016\/j.phymed.2022.154401","journal-title":"Phytomedicine"},{"issue":"11","key":"11610_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-023-03765-y","volume":"13","author":"R Mirabbasi","year":"2023","unstructured":"Mirabbasi R, Ebrahimi SO, Tavakoli F, Reiisi S (2023) Novel polymorphism rs12402181 in the mature sequence of hsa-miR-3117-3p has a protective effect against breast cancer development by affecting miRNA processing and function. 3 Biotech 13(11):349. https:\/\/doi.org\/10.1007\/s13205-023-03765-y","journal-title":"3 Biotech"},{"issue":"7","key":"11610_CR49","first-page":"3093","volume":"30","author":"E Canbay","year":"2010","unstructured":"Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E (2010) CCND1 and CDKN1B polymorphisms and risk of breast cancer. Anticancer Res 30(7):3093\u20133098","journal-title":"Anticancer Res"},{"key":"11610_CR50","unstructured":"Comisso E (2016) OCT4 promuove l\u2019aggressivit\u00e0 del tumore ovarico sieroso ad alto grado attraverso l\u2019inattivazione di pRB e l\u2019aumento della stabilit\u00e0 genomica"},{"issue":"3","key":"11610_CR51","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/1055-9965.EPI-08-0860","volume":"18","author":"EL Goode","year":"2009","unstructured":"Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, White KL, Pankratz VS, Song H (2009) Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 18(3):935\u2013944. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0860","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"11610_CR52","doi-asserted-by":"publisher","first-page":"8697","DOI":"10.1007\/s13277-015-3623-8","volume":"36","author":"J Long","year":"2015","unstructured":"Long J, Ou C, Xia H, Zhu Y, Liu D (2015) MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression. Tumor Biol 36:8697\u20138702","journal-title":"Tumor Biol"},{"key":"11610_CR53","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1023\/A:1023033708204","volume":"78","author":"CJ Ormandy","year":"2003","unstructured":"Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL (2003c) Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 78:323\u2013335","journal-title":"Breast Cancer Res Treat"},{"key":"11610_CR54","doi-asserted-by":"crossref","unstructured":"Montesano R, Holestein M, Hainaui P (1996) Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 69(3):225\u2013235.","DOI":"10.1002\/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6"},{"issue":"4","key":"11610_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/carcin\/20.4.591","volume":"20","author":"ST Shi","year":"1999","unstructured":"Shi ST, Yang G-Y, Wang L-D, Xue Z, Feng B, Ding W, Xing EP, Yang CS (1999) Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis 20(4):591\u2013597. https:\/\/doi.org\/10.1093\/carcin\/20.4.591","journal-title":"Carcinogenesis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11610-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:33:47Z","timestamp":1772192027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11610-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11610"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11610-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7532323\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no-conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval (Certificate No. 109\/IRC\/BMR, dated 19.10.2020) was obtained from the Institutional Review Committee for Biomedical Research, University of Veterinary and Animal Sciences, Lahore. Tissue samples were collected with informed consent from patients following the surgical excision of tumors, in accordance with prior clinical diagnosis and medical recommendation for tumor removal surgery.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}],"article-number":"439"}}